International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center

This study has been completed.
Sponsor:
Collaborator:
Weill Medical College of Cornell University
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01504152
First received: January 3, 2012
Last updated: July 11, 2013
Last verified: July 2013
  Purpose

The purpose of this study is to survey patients who underwent hematopoietic stem cell transplant (HSCT) to assess if they have traveled or not internationally after transplant. This information will help to improve the understanding of the needs for travel health strategies and interventions to provide healthy and safe travel to HSCT patients. The findings of this survey will also be used to develop travel health related interventions for patients living with cancer as well.


Condition Intervention
Hematopoietic Stem Cell Transplant
Behavioral: questionnaire

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Survey to Assess International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center

Resource links provided by NLM:


Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • prevalence of international travel [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    of the targeted patients Proportion of Hematopoietic Stem Cell Transplant (HSCT) patients who traveled internationally within two years after HSCT


Secondary Outcome Measures:
  • international travel was during a high-risk specific period [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    Proportion of patients traveling to destinations that are at high risk areas for infections

  • patients that sought pre-travel health advice [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    among those who traveled to high risk areas for infections

  • travelers that becomes ill and required medical attention [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    during or after return from international travel.


Enrollment: 519
Study Start Date: December 2011
Study Completion Date: July 2013
Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
patients who received HSCT at MSKCC between 2005-2010
A self-administered patient questionnaire will be used to collect data that will assess the prevalence of international travel after HSCT and travel related morbidity and exposure risks among HSCT recipients.
Behavioral: questionnaire
The intervention is a self-administered questionnaire that is voluntarily completed by the subject. This questionnaire has been previously validated and demonstrated to be reproducible in English speaking travelers. The final version of the survey questionnaire consists of 49 questions.Patients who never traveled after HSCT will answer only eighteen questions related to their medical and HSCT history in addition to their demographics.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients who received HSCT at MSKCC between 2005-2010 and were alive after the first year after HSCT.

Criteria

Inclusion Criteria:

  • Hematopoietic Stem Cell Transplant (HSCT) recipients at MSKCC from 1/1/2005 to 12/31/2010.
  • Age at HSCT ≥ 18 years
  • Permanent mailing address in the United States of America

Exclusion Criteria:

  • Subject unable to fill the questionnaire due to language barriers.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01504152

Locations
United States, New York
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
Weill Medical College of Cornell University
Investigators
Principal Investigator: Monika Shah, MD Memorial Sloan-Kettering Cancer Center
  More Information

Additional Information:
No publications provided

Responsible Party: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT01504152     History of Changes
Other Study ID Numbers: 11-176
Study First Received: January 3, 2012
Last Updated: July 11, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Memorial Sloan-Kettering Cancer Center:
International travel
cancer patients
HSCT
Quality of Life
questionnaire
11-176

ClinicalTrials.gov processed this record on August 01, 2014